Ross Osborn Analyst Performance

Ross Osborn is a stock analyst at Cantor Fitzgerald focused in the medical sector, covering 15 publicly traded companies. Over the past year, Ross Osborn has issued 25 stock ratings, including buy and hold recommendations. While full access to Ross Osborn's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ross Osborn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

25 Last 0 Years

Buy Recommendations

96.00% 24 Buy Ratings

Companies Covered

15 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	96.0%	24 ratings
Hold	4.0%	1 ratings
Sell	0.0%	0 ratings

Out of 25 total stock ratings issued by Ross Osborn at Cantor Fitzgerald, the majority (96.0%) have been Buy recommendations, followed by 4.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	93.3% of companies on NASDAQ	14 companies
NYSE	6.7% of companies on NYSE	1 company

Ross Osborn, an analyst at Cantor Fitzgerald, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 14 companies	93.3%
	Business Services 1 company	6.7%

Ross Osborn of Cantor Fitzgerald specializes in stock coverage within the Medical sector, with additional focus on Business Services companies.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 5 companies	33.3%
MED PRODUCTS 4 companies	26.7%
MED - BIOMED/GENE 3 companies	20.0%
MED - DRUGS 1 company	6.7%
SURGICAL & MEDICAL INSTRUMENTS 1 company	6.7%
TECHNOLOGY SERVICES 1 company	6.7%

Ross Osborn's Ratings History at Cantor Fitzgerald

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
SIBN SiBone	8/11/2025	Set Price Target	$15.68	$25.00	Overweight	$0.00 00.00% ROI
ORGO Organogenesis	8/8/2025	Boost Price Target	$4.17	$9.00	Overweight	$0.00 00.00% ROI
LMAT LeMaitre Vascular	8/6/2025	Boost Price Target	$94.31	$95.00	Neutral	$0.00 00.00% ROI
CVRX CVRx	8/5/2025	Reiterated Rating	$7.55	$11.00	Overweight	$0.00 00.00% ROI
SIBN SiBone	8/5/2025	Reiterated Rating	$17.90	$25.00	Overweight	$0.00 00.00% ROI
MDXG MiMedx Group	7/31/2025	Boost Price Target	$6.52	$12.00	Overweight	$0.00 00.00% ROI
MDXG MiMedx Group	7/15/2025	Reiterated Rating	$6.80	$11.00	Overweight	$0.00 00.00% ROI
ORGO Organogenesis	7/15/2025	Reiterated Rating	$4.49	$7.00	Overweight	$0.00 00.00% ROI
BVS Bioventus	7/7/2025	Initiated Coverage	$7.14	$12.00	Overweight	$0.00 00.00% ROI
XGN Exagen	5/15/2025	Lower Price Target	$5.90	$7.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
LUCD Lucid Diagnostics	5/15/2025	Reiterated Rating	$1.26	$2.00	Overweight	$0.00 00.00% ROI
NPCE NeuroPace	5/14/2025	Reiterated Rating	$14.58	$17.00	Overweight	$0.00 00.00% ROI
SIBN SiBone	5/6/2025	Reiterated Rating	$14.25	$25.00	Overweight	$0.00 00.00% ROI
NNOX Nano-X Imaging	4/1/2025	Lower Price Target	$5.03	$9.00	Overweight	$0.00 00.00% ROI
SMTI Sanara MedTech	3/26/2025	Reiterated Rating	$30.06	$46.00	Overweight	$0.00 00.00% ROI
LUCD Lucid Diagnostics	3/26/2025	Reiterated Rating	$1.56	$2.00	Overweight	$0.00 00.00% ROI
ELUT Elutia	3/7/2025	Reiterated Rating	$2.46	$8.00	Overweight	$0.00 00.00% ROI
AXGN AxoGen	3/5/2025	Reiterated Rating	$18.13	$24.00	Overweight	$0.00 00.00% ROI
NPCE NeuroPace	3/5/2025	Boost Price Target	$11.22	$20.00	Overweight	$0.00 00.00% ROI
MDXG MiMedx Group	2/27/2025	Reiterated Rating	$8.24	$13.00	Overweight	$0.00 00.00% ROI
SIBN SiBone	2/25/2025	Reiterated Rating	$19.10	$25.00	Overweight	$0.00 00.00% ROI
CERS Cerus	2/21/2025	Reiterated Rating	$1.70	$4.00	Overweight	$0.00 00.00% ROI
SMTI Sanara MedTech	1/22/2025	Reiterated Rating	$37.31	$44.00	Overweight	$0.00 00.00% ROI
PRE Prenetics Global	1/16/2025	Reiterated Rating	$6.00	$9.00	Overweight	$0.00 00.00% ROI
XGN Exagen	1/13/2025	Reiterated Rating	$3.17	$8.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.